Carlomaurizio Montecucco

Author

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Arti Mahto, C A Montecucco, C M Montecucco, C MONTECUCCO, C Montecucco, C. M. MONTECUCCO, C. M. Montecucco, C. MONTECUCCO, C. Montecucco, C.M Montecucco

851

Publications

22.7K

Citations

H-Index

182

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico University of Pavia Policlinico San Matteo Fondazione Sapienza University of Rome University of Pisa

About

Carlomaurizio Montecucco is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, rheumatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	72	3.1K
2	Health Sciences	13	16	464
3	Public Health	8	8	368
4	Natural Sciences	3	3	58
5	Engineering	2	2	80

Carlomaurizio Montecucco

256

Publications

14.4K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Maxime Dougados, Martin Soubrier, Anna Antunez, Annals of the Rheumatic Diseases	2013	841
Mapping and predicting mortality from systemic sclerosis Muriel Elhaï, Christophe Meune, Marouane Boubaya, Annals of the Rheumatic Diseases	2017	642
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse Carlo Alberto Scirè, Carlomaurizio Montecucco, Veronica Codullo, Lara D. Veeken	2009	296
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial Frances Humby, Patrick Durez, Maya H Buch, The Lancet	2021	285
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study Anna Moltó, Adrien Etcheto, Désirée van der Heijde, Annals of the Rheumatic Diseases	2015	256
Prednisone plus Methotrexate for Polymyalgia Rheumatica Roberto Caporali, Marco A. Cimmino, Gianfranco Ferraccioli, Annals of Internal Medicine	2004	249
Systematic microanatomical analysis of CXCL13 and CCL21 <i>in situ</i> production and progressive lymphoid organization in rheumatoid synovitis Antonio Manzo, Samantha Paoletti, Maresa Carulli, European Journal of Immunology Lymphocyte DevelopmentImmunologyPathologyImmunologic MechanismImmunotherapy	2005	248
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE) Marta Colaneri, Laura Bogliolo, Pietro Valsecchi, Microorganisms	2020	216
Sjögren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients Claudio Vitali, G Palombi, Chiara Baldini, Arthritis & Rheumatism	2007	205
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course Lorenzo Cavagna, Ernesto Trallero‐Araguás, Federica Meloni, Journal of Clinical Medicine AsthmaRheumatologyAntisynthetase SyndromeRheumatoid DisorderAutoimmune Disease	2019	200

Page 1